PDCD4

programmed cell death 4, the group of MicroRNA protein coding host genes

Basic information

Region (hg38): 10:110871794-110900006

Links

ENSG00000150593NCBI:27250OMIM:608610HGNC:8763Uniprot:Q53EL6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PDCD4 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDCD4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
15
clinvar
15
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 15 0 2

Variants in PDCD4

This is a list of pathogenic ClinVar variants found in the PDCD4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-110881291-G-A Benign (Jun 06, 2018)747235
10-110881394-C-T not specified Uncertain significance (Oct 25, 2022)2318969
10-110881416-C-T not specified Uncertain significance (Dec 13, 2021)2266469
10-110881428-G-T not specified Uncertain significance (Jan 26, 2023)2464430
10-110881439-G-A not specified Uncertain significance (May 04, 2022)2313740
10-110883009-C-T not specified Uncertain significance (Jun 07, 2023)2559019
10-110885317-C-A not specified Uncertain significance (Mar 30, 2024)3305310
10-110885328-C-A not specified Uncertain significance (May 20, 2024)3305311
10-110887670-G-A not specified Uncertain significance (Apr 07, 2022)2281521
10-110887846-A-T not specified Uncertain significance (Mar 14, 2023)2495860
10-110889623-C-G not specified Uncertain significance (Jan 04, 2024)3210580
10-110890623-T-G not specified Uncertain significance (Apr 23, 2024)3305309
10-110890645-A-G not specified Uncertain significance (Dec 01, 2022)2240463
10-110894099-G-C not specified Uncertain significance (Dec 22, 2023)3210581
10-110894119-T-C not specified Uncertain significance (Feb 13, 2024)3210577
10-110894182-A-G not specified Uncertain significance (Oct 13, 2023)3210578
10-110894445-A-G not specified Uncertain significance (Jan 19, 2024)3210579
10-110894480-C-T Benign (May 21, 2018)710229
10-110895964-A-G not specified Uncertain significance (Jul 05, 2023)2609823
10-110896009-C-G not specified Uncertain significance (Jul 25, 2023)2592040

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PDCD4protein_codingprotein_codingENST00000280154 1128200
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.36e-70.9381257040441257480.000175
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2182392490.9610.00001233063
Missense in Polyphen7794.5090.814741158
Synonymous-0.1779289.91.020.00000467891
Loss of Function1.831423.60.5930.00000116318

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004030.000397
Ashkenazi Jewish0.000.00
East Asian0.0001650.000163
Finnish0.00004620.0000462
European (Non-Finnish)0.0002040.000202
Middle Eastern0.0001650.000163
South Asian0.0002150.000196
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA (By similarity). {ECO:0000250, ECO:0000269|PubMed:16357133, ECO:0000269|PubMed:16449643, ECO:0000269|PubMed:17053147, ECO:0000269|PubMed:18296639, ECO:0000269|PubMed:19153607, ECO:0000269|PubMed:19204291}.;
Pathway
Proteoglycans in cancer - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interferon type I signaling pathways;mTOR signaling pathway (Consensus)

Recessive Scores

pRec
0.146

Intolerance Scores

loftool
0.943
rvis_EVS
-0.16
rvis_percentile_EVS
42.06

Haploinsufficiency Scores

pHI
0.613
hipred
Y
hipred_score
0.703
ghis
0.503

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.877

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pdcd4
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; neoplasm; immune system phenotype; renal/urinary system phenotype; endocrine/exocrine gland phenotype;

Zebrafish Information Network

Gene name
pdcd4b
Affected structure
atrioventricular valve
Phenotype tag
abnormal
Phenotype quality
constricted

Gene ontology

Biological process
apoptotic process;cell aging;BMP signaling pathway;interleukin-12-mediated signaling pathway;negative regulation of apoptotic process;negative regulation of JUN kinase activity;negative regulation of cell cycle;negative regulation of transcription, DNA-templated;positive regulation of inflammatory response;epithelial to mesenchymal transition involved in cardiac fibroblast development;cellular response to lipopolysaccharide;negative regulation of cytokine production involved in inflammatory response;positive regulation of NIK/NF-kappaB signaling;negative regulation of vascular smooth muscle cell proliferation;negative regulation of myofibroblast differentiation;negative regulation of vascular smooth muscle cell differentiation;positive regulation of vascular associated smooth muscle cell apoptotic process;positive regulation of endothelial cell apoptotic process
Cellular component
nucleus;cytoplasm;cytosol
Molecular function
RNA binding;protein binding